TreeWAS – Variant ID: rs6984305

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E78.0 Pure hypercholesterolaemia	0.454	0.546	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.261	0.739	0.000
E78.8 Other disorders of lipoprotein metabolism	0.233	0.767	0.000
E78.9 Disorder of lipoprotein metabolism, unspecified	0.211	0.789	0.000
E78.3 Hyperchylomicronaemia	0.202	0.798	0.000
E78.1 Pure hyperglyceridaemia	0.189	0.811	0.000
E78.5 Hyperlipidaemia, unspecified	0.180	0.820	0.000
E78.6 Lipoprotein deficiency	0.179	0.821	0.000
E78.4 Other hyperlipidaemia	0.158	0.841	0.000
E78.2 Mixed hyperlipidaemia	0.151	0.849	0.000
N62 Hypertrophy of breast	0.041	0.959	0.000
N64 Other disorders of breast	0.033	0.967	0.000
N64.1 Fat necrosis of breast	0.032	0.968	0.000
N60-N64 Disorders of breast	0.032	0.968	0.000
N64.4 Mastodynia	0.028	0.972	0.000
N61 Inflammatory disorders of breast	0.028	0.972	0.000
N64.9 Disorder of breast, unspecified	0.027	0.973	0.000
M75.0 Adhesive capsulitis of shoulder	0.000	0.974	0.026
I10 Essential (primary) hypertension	0.000	0.974	0.026
N64.3 Galactorrhoea not associated with childbirth	0.025	0.975	0.000
N64.5 Other signs and symptoms in breast	0.024	0.976	0.000
N64.0 Fissure and fistula of nipple	0.023	0.976	0.000
N64.2 Atrophy of breast	0.023	0.977	0.000
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.000	0.980	0.020
N60 Benign mammary dysplasia	0.017	0.983	0.000
N63 Unspecified lump in breast	0.016	0.984	0.000
N60.2 Fibroadenosis of breast	0.015	0.985	0.000
N64.8 Other specified disorders of breast	0.013	0.987	0.000
N60.4 Mammary duct ectasia	0.013	0.987	0.000
N60.3 Fibrosclerosis of breast	0.013	0.987	0.000
N60.9 Benign mammary dysplasia, unspecified	0.012	0.987	0.000
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.000	0.988	0.012
D17 Benign lipomatous neoplasm	0.000	0.989	0.011
R16.1 Splenomegaly, not elsewhere classified	0.010	0.990	0.000
D17.9 Benign lipomatous neoplasm, unspecified	0.000	0.990	0.010
J44.9 Chronic obstructive pulmonary disease, unspecified	0.000	0.991	0.009
N60.1 Diffuse cystic mastopathy	0.009	0.991	0.000
N60.0 Solitary cyst of breast	0.009	0.991	0.000
N60.8 Other benign mammary dysplasias	0.009	0.991	0.000
T51.9 Alcohol, unspecified	0.000	0.992	0.008
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.992	0.008
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.000	0.992	0.008
T51.0 Ethanol	0.000	0.992	0.008
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.000	0.992	0.008
T51 Toxic effect of alcohol	0.000	0.993	0.007
H71 Cholesteatoma of middle ear	0.000	0.993	0.007
I85.9 Oesophageal varices without bleeding	0.007	0.993	0.000
C50.9 Breast, unspecified	0.007	0.993	0.000
H18.2 Other corneal oedema	0.000	0.994	0.006
L03.1 Cellulitis of other parts of limb	0.000	0.994	0.006
R25.2 Cramp and spasm	0.000	0.994	0.006
H18 Other disorders of cornea	0.000	0.994	0.006
E83.4 Disorders of magnesium metabolism	0.006	0.994	0.000
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.994	0.006
T51.8 Other alcohols	0.000	0.994	0.005
T51.3 Fusel oil	0.000	0.994	0.005
T51.2 2-Propanol	0.000	0.994	0.005
T51.1 Methanol	0.000	0.994	0.005
I10-I15 Hypertensive diseases	0.000	0.994	0.005
H18.0 Corneal pigmentations and deposits	0.000	0.995	0.005
H18.8 Other specified disorders of cornea	0.000	0.995	0.005
H18.6 Keratoconus	0.000	0.995	0.005
I15 Secondary hypertension	0.000	0.995	0.005
H18.5 Hereditary corneal dystrophies	0.000	0.995	0.005
E83 Disorders of mineral metabolism	0.005	0.995	0.000
H18.3 Changes in corneal membranes	0.000	0.995	0.005
H18.7 Other corneal deformities	0.000	0.995	0.005
Z94.8 Other transplanted organ and tissue status	0.005	0.995	0.000
Z94.0 Kidney transplant status	0.005	0.995	0.000
E70-E90 Metabolic disorders	0.005	0.995	0.000
E83.1 Disorders of iron metabolism	0.005	0.995	0.000
I85 Oesophageal varices	0.005	0.995	0.000
H18.9 Disorder of cornea, unspecified	0.000	0.996	0.004
H18.4 Corneal degeneration	0.000	0.996	0.004
I15.9 Seconday hypertension, unspecified	0.000	0.996	0.004
I85.0 Oesophageal varices with bleeding	0.004	0.996	0.000
H18.1 Bullous keratopathy	0.000	0.996	0.004
I15.0 Renovascular hypertension	0.000	0.996	0.004
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.004	0.996	0.000
I15.2 Hypertension secondary to endocrine disorders	0.000	0.996	0.004
Z94 Transplanted organ and tissue status	0.004	0.996	0.000
Z94.4 Liver transplant status	0.004	0.996	0.000
I15.8 Other secondary hypertension	0.000	0.996	0.004
Z85.5 Personal history of malignant neoplasm of urinary tract	0.004	0.996	0.000
I13 Hypertensive heart and renal disease	0.000	0.996	0.004
Z42.1 Follow-up care involving plastic surgery of breast	0.004	0.996	0.000
E70 Disorders of aromatic amino-acid metabolism	0.004	0.996	0.000
E83.8 Other disorders of mineral metabolism	0.004	0.996	0.000
E83.2 Disorders of zinc metabolism	0.004	0.996	0.000
E83.0 Disorders of copper metabolism	0.004	0.996	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.004	0.996	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.000	0.996	0.004
E79 Disorders of purine and pyrimidine metabolism	0.004	0.996	0.000
E74 Other disorders of carbohydrate metabolism	0.004	0.996	0.000
E77 Disorders of glycoprotein metabolism	0.004	0.996	0.000
E72 Other disorders of amino-acid metabolism	0.004	0.996	0.000
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.000	0.996	0.004
I15.1 Hypertension secondary to other renal disorders	0.000	0.996	0.004
E76 Disorders of glycosaminoglycan metabolism	0.004	0.996	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.004	0.996	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.004	0.996	0.000
E73 Lactose intolerance	0.003	0.996	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.003	0.997	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.003	0.997	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.997	0.003
Z94.6 Bone transplant status	0.003	0.997	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.997	0.003
Z94.1 Heart transplant status	0.003	0.997	0.000
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)	0.000	0.997	0.003
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.003	0.997	0.000
T63 Toxic effect of contact with venomous animals	0.000	0.997	0.003
E85 Amyloidosis	0.003	0.997	0.000
E70.3 Albinism	0.003	0.997	0.000
Z94.5 Skin transplant status	0.003	0.997	0.000
Z94.9 Transplanted organ and tissue status, unspecified	0.003	0.997	0.000
T58 Toxic effect of carbon monoxide	0.000	0.997	0.003
T56 Toxic effect of metals	0.000	0.997	0.003
I11 Hypertensive heart disease	0.000	0.997	0.003
Z94.3 Heart and lungs transplant status	0.003	0.997	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.997	0.003
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.997	0.003
T54 Toxic effect of corrosive substances	0.000	0.997	0.003
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.003	0.997	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.003	0.997	0.000
E70.2 Disorders of tyrosine metabolism	0.003	0.997	0.000
E70.1 Other hyperphenylalaninaemias	0.003	0.997	0.000
E70.0 Classical phenylketonuria	0.003	0.997	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.003	0.997	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.003	0.997	0.000
Z94.7 Corneal transplant status	0.003	0.997	0.000
E83.3 Disorders of phosphorus metabolism	0.003	0.997	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.003	0.997	0.000
R25 Abnormal involuntary movements	0.000	0.997	0.003
T52 Toxic effect of organic solvents	0.000	0.997	0.003
T63.4 Venom of other arthropods	0.000	0.997	0.003
T60 Toxic effect of pesticides	0.000	0.997	0.003
T57 Toxic effect of other inorganic substances	0.000	0.997	0.003
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.000	0.997	0.003
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.000	0.997	0.003
E84 Cystic fibrosis	0.003	0.997	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.003	0.997	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.003	0.997	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.003	0.997	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.003	0.997	0.000
E74.2 Disorders of galactose metabolism	0.003	0.997	0.000
E74.1 Disorders of fructose metabolism	0.003	0.997	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.003	0.997	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.003	0.997	0.000
E79.1 Lesch-Nyhan syndrome	0.003	0.997	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.997	0.003
E74.0 Glycogen storage disease	0.003	0.997	0.000
E77.8 Other disorders of glycoprotein metabolism	0.003	0.997	0.000
H81.0 Meniere's disease	0.003	0.997	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.003	0.997	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.003	0.997	0.000
E72.5 Disorders of glycine metabolism	0.003	0.997	0.000
E72.4 Disorders of ornithine metabolism	0.003	0.997	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.003	0.997	0.000
E72.2 Disorders of urea cycle metabolism	0.003	0.997	0.000
E72.0 Disorders of amino-acid transport	0.003	0.997	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.003	0.997	0.000
E77.1 Defects in glycoprotein degradation	0.003	0.997	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.003	0.997	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.997	0.003
E71.3 Disorders of fatty-acid metabolism	0.003	0.997	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.003	0.997	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.003	0.997	0.000
E71.0 Maple-syrup-urine disease	0.003	0.997	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.003	0.997	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.003	0.997	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.003	0.997	0.000
E76.2 Other mucopolysaccharidoses	0.003	0.997	0.000
E76.1 Mucopolysaccharidosis, type II	0.003	0.997	0.000
E76.0 Mucopolysaccharidosis, type I	0.003	0.997	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.000	0.997	0.003
Z94.2 Lung transplant status	0.003	0.997	0.000
T59 Toxic effect of other gases, fumes and vapours	0.000	0.997	0.003
T56.8 Other metals	0.000	0.997	0.003
T62 Toxic effect of other noxious substances eaten as food	0.000	0.997	0.003
T55 Toxic effect of soaps and detergents	0.000	0.997	0.003
F22.0 Delusional disorder	0.000	0.997	0.003
E73.8 Other lactose intolerance	0.003	0.997	0.000
E73.1 Secondary lactase deficiency	0.003	0.997	0.000
E73.0 Congenital lactase deficiency	0.003	0.997	0.000
T65 Toxic effect of other and unspecified substances	0.000	0.997	0.003
E75.6 Lipid storage disorder, unspecified	0.003	0.997	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.003	0.997	0.000
E75.3 Sphingolipidosis, unspecified	0.003	0.997	0.000
E75.1 Other gangliosidosis	0.003	0.997	0.000
E75.0 GM2 gangliosidosis	0.003	0.997	0.000
E85.8 Other amyloidosis	0.003	0.997	0.000
E83.5 Disorders of calcium metabolism	0.003	0.997	0.000
T63.9 Toxic effect of contact with unspecified venomous animal	0.000	0.997	0.003
E73.9 Lactose intolerance, unspecified	0.003	0.997	0.000
E75.5 Other lipid storage disorders	0.002	0.997	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.002	0.997	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.002	0.997	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.002	0.997	0.000
T63.8 Toxic effect of contact with other venomous animals	0.000	0.997	0.002
T63.6 Toxic effect of contact with other marine animals	0.000	0.997	0.002
T63.5 Toxic effect of contact with fish	0.000	0.997	0.002
T63.3 Venom of spider	0.000	0.997	0.002
T63.2 Venom of scorpion	0.000	0.997	0.002
T63.1 Venom of other reptiles	0.000	0.997	0.002
T63.0 Snake venom	0.000	0.997	0.002
E75.2 Other sphingolipidosis	0.002	0.997	0.000
E85.4 Organ-limited amyloidosis	0.002	0.997	0.000
T56.9 Metal, unspecified	0.000	0.997	0.002
T56.7 Beryllium and its compounds	0.000	0.997	0.002
T56.6 Tin and its compounds	0.000	0.997	0.002
T56.5 Zinc and its compounds	0.000	0.997	0.002
T56.4 Copper and its compounds	0.000	0.997	0.002
T56.3 Cadmium and its compounds	0.000	0.997	0.002
T56.2 Chromium and its compounds	0.000	0.997	0.002
T56.1 Mercury and its compounds	0.000	0.997	0.002
T56.0 Lead and its compounds	0.000	0.997	0.002
R03.1 Nonspecific low blood-pressure reading	0.000	0.997	0.003
R25.8 Other and unspecified abnormal involuntary movements	0.000	0.997	0.003
C32.0 Glottis	0.000	0.997	0.003
T54.9 Corrosive substance, unspecified	0.000	0.997	0.002
S52.60 Fracture of lower end of both ulna and radius (closed)	0.002	0.997	0.000
R25.3 Fasciculation	0.000	0.997	0.002
T52.8 Other organic solvents	0.000	0.997	0.002
T54.3 Corrosive alkalis and alklali-like substances	0.000	0.997	0.002
T54.2 Corrosive acids and acid-like substances	0.000	0.997	0.002
T54.1 Other corrosive organic compounds	0.000	0.997	0.002
T54.0 Phenol and phenol homologues	0.000	0.997	0.002
E85.3 Secondary systemic amyloidosis	0.002	0.998	0.000
R25.0 Abnormal head movements	0.000	0.998	0.002
T52.9 Organic solvent, unspecified	0.000	0.998	0.002
T52.4 Ketones	0.000	0.998	0.002
T52.3 Glycols	0.000	0.998	0.002
T52.2 Homologues of benzene	0.000	0.998	0.002
T52.1 Benzene	0.000	0.998	0.002
T52.0 Petroleum products	0.000	0.998	0.002
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.000	0.998	0.002
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.000	0.998	0.002
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.000	0.998	0.002
T53.5 Chlorofluorocarbons	0.000	0.998	0.002
T53.4 Dichloromethane	0.000	0.998	0.002
T53.3 Tetrachloroethylene	0.000	0.998	0.002
T53.2 Trichloroethylene	0.000	0.998	0.002
T53.1 Chloroform	0.000	0.998	0.002
T53.0 Carbon tetrachloride	0.000	0.998	0.002
T57.9 Inorganic substance, unspecified	0.000	0.998	0.002
T57.8 Other specified inorganic substances	0.000	0.998	0.002
T57.3 Hydrogen cyanide	0.000	0.998	0.002
T57.2 Manganese and its compounds	0.000	0.998	0.002
T57.1 Phosphorus and its compounds	0.000	0.998	0.002
T57.0 Arsenic and its compounds	0.000	0.998	0.002
T60.9 Pesticide, unspecified	0.000	0.998	0.002
T60.8 Other pesticides	0.000	0.998	0.002
T60.4 Rodenticides	0.000	0.998	0.002
T60.3 Herbicides and fungicides	0.000	0.998	0.002
T60.2 Other insecticides	0.000	0.998	0.002
T60.1 Halogenated insecticides	0.000	0.998	0.002
T60.0 Organophosphate and carbamate insecticides	0.000	0.998	0.002
E85.9 Amyloidosis, unspecified	0.002	0.998	0.000
E84.8 Cystic fibrosis with other manifestations	0.002	0.998	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.002	0.998	0.000
H05.0 Acute inflammation of orbit	0.000	0.998	0.002
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.998	0.002
I49.3 Ventricular premature depolarisation	0.002	0.998	0.000
T59.7 Carbon dioxide	0.000	0.998	0.002
T59.6 Hydrogen sulphide	0.000	0.998	0.002
T59.5 Fluorine gas and hydrogen fluoride	0.000	0.998	0.002
T59.4 Chlorine gas	0.000	0.998	0.002
T59.3 Lachrymogenic gas	0.000	0.998	0.002
T59.2 Formaldehyde	0.000	0.998	0.002
T59.1 Sulphur dioxide	0.000	0.998	0.002
T59.0 Nitrogen oxides	0.000	0.998	0.002
T61.9 Toxic effect of unspecified seafood	0.000	0.998	0.002
T61.8 Toxic effect of other seafoods	0.000	0.998	0.002
T61.1 Scombroid fish poisoning	0.000	0.998	0.002
T61.0 Ciguatera fish poisoning	0.000	0.998	0.002
T62.8 Other specified noxious substances eaten as food	0.000	0.998	0.002
T62.2 Other ingested (parts of) plant(s)	0.000	0.998	0.002
T62.1 Ingested berries	0.000	0.998	0.002
T62.0 Ingested mushrooms	0.000	0.998	0.002
I49.9 Cardiac arrhythmia, unspecified	0.002	0.998	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.002	0.998	0.000
R25.1 Tremor, unspecified	0.000	0.998	0.002
T59.8 Other specified gases, fumes and vapours	0.000	0.998	0.002
T65.8 Toxic effect of other specified substances	0.000	0.998	0.002
T65.6 Paints and dyes, not elsewhere classified	0.000	0.998	0.002
T65.5 Nitroglycerin and other nitric acids and esters	0.000	0.998	0.002
T65.4 Carbon disulphide	0.000	0.998	0.002
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.000	0.998	0.002
T65.2 Tobacco and nicotine	0.000	0.998	0.002
T65.1 Strychnine and its salts	0.000	0.998	0.002
T65.0 Cyanides	0.000	0.998	0.002
T59.9 Gases, fumes and vapours, unspecified	0.000	0.998	0.002
E84.0 Cystic fibrosis with pulmonary manifestations	0.002	0.998	0.001
T61.2 Other fish and shellfish poisoning	0.000	0.998	0.002
T62.9 Noxious substance eaten as food, unspecified	0.000	0.998	0.002
C44.2 Skin of ear and external auricular canal	0.000	0.998	0.002
M79.0 Rheumatism, unspecified	0.000	0.998	0.002
Z12.1 Special screening examination for neoplasm of intestinal tract	0.002	0.998	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.998	0.002
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.998	0.002
C32.9 Larynx, unspecified	0.000	0.998	0.002
D86.0 Sarcoidosis of lung	0.002	0.998	0.000
E84.9 Cystic fibrosis, unspecified	0.001	0.998	0.001
O20.8 Other haemorrhage in early pregnancy	0.000	0.998	0.002
C50.2 Upper-inner quadrant of breast	0.002	0.998	0.000
T65.9 Toxic effect of unspecified substance	0.000	0.998	0.002
Z88.8 Personal history of allergy to other drugs, medicaments and biological substances	0.000	0.998	0.002
E88 Other metabolic disorders	0.002	0.998	0.000
O62.3 Precipitate labour	0.002	0.998	0.000
C67.9 Bladder, unspecified	0.002	0.998	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.998	0.002
J84.1 Other interstitial pulmonary diseases with fibrosis	0.002	0.998	0.000
C67.5 Bladder neck	0.002	0.998	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.998	0.002
Q63.0 Accessory kidney	0.000	0.998	0.002
M54.59 Low back pain (Site unspecified)	0.000	0.998	0.002
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.998	0.002
C67.4 Posterior wall of bladder	0.002	0.998	0.000
N20.1 Calculus of ureter	0.002	0.998	0.000
D86 Sarcoidosis	0.002	0.998	0.000
C67.1 Dome of bladder	0.002	0.998	0.000
E80.5 Crigler-Najjar syndrome	0.002	0.998	0.000
E80.3 Defects of catalase and peroxydase	0.002	0.998	0.000
E80.0 Hereditary erythropoietic porphyria	0.002	0.998	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.000	0.998	0.002
C50.4 Upper-outer quadrant of breast	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
E80.1 Porphyria cutanea tarda	0.002	0.998	0.000
O03.9 Complete or unspecified, without complication	0.000	0.998	0.002
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.002	0.998	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.002	0.998	0.000
C32 Malignant neoplasm of larynx	0.000	0.998	0.002
E80.6 Other disorders of bilirubin metabolism	0.002	0.998	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.002	0.998	0.000
I49 Other cardiac arrhythmias	0.002	0.998	0.000
S09.9 Unspecified injury of head	0.000	0.998	0.002
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M79.04 Rheumatism, unspecified (Hand)	0.000	0.998	0.002
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.998	0.002
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.998	0.002
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.998	0.002
D86.1 Sarcoidosis of lymph nodes	0.002	0.998	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.001	0.998	0.001
I49.4 Other and unspecified premature depolarisation	0.002	0.998	0.000
C67 Malignant neoplasm of bladder	0.002	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.002	0.998	0.000
H53.0 Amblyopia ex anopsia	0.000	0.998	0.002
C50 Malignant neoplasm of breast	0.002	0.998	0.000
I12 Hypertensive renal disease	0.000	0.998	0.002
D59.1 Other autoimmune haemolytic anaemias	0.002	0.998	0.000
E80.2 Other porphyria	0.001	0.998	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.998	0.002
E89.4 Postprocedural ovarian failure	0.002	0.998	0.000
M75.9 Shoulder lesion, unspecified	0.000	0.998	0.002
N92.6 Irregular menstruation, unspecified	0.000	0.998	0.002
A87.9 Viral meningitis, unspecified	0.000	0.998	0.002
C32.2 Subglottis	0.000	0.998	0.002
D86.3 Sarcoidosis of skin	0.002	0.998	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.002	0.998	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.001	0.998	0.000
I49.5 Sick sinus syndrome	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.000	0.998	0.002
E88.8 Other specified metabolic disorders	0.001	0.998	0.000
H80.9 Otosclerosis, unspecified	0.002	0.998	0.000
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.002	0.998	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
E88.3 Tumour lysis syndrome	0.001	0.998	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.002	0.998	0.000
F31.9 Bipolar affective disorder, unspecified	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
E88.9 Metabolic disorder, unspecified	0.001	0.998	0.000
E89.5 Postprocedural testicular hypofunction	0.002	0.998	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.002	0.998	0.000
M75 Shoulder lesions	0.000	0.998	0.002
M79.08 Rheumatism, unspecified (Other)	0.000	0.998	0.001
C50.6 Axillary tail of breast	0.002	0.998	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.001	0.998	0.000
E89.1 Postprocedural hypoinsulinaemia	0.001	0.998	0.000
I49.1 Atrial premature depolarisation	0.002	0.998	0.000
S52.61 Fracture of lower end of both ulna and radius (open)	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.000	0.998	0.001
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
E89.8 Other postprocedural endocrine and metabolic disorders	0.001	0.998	0.000
I49.2 Junctional premature depolarisation	0.001	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.002	0.998	0.000
M71.2 Synovial cyst of popliteal space [Baker]	0.000	0.998	0.002
O62 Abnormalities of forces of labour	0.002	0.998	0.000
C32.3 Laryngeal cartilage	0.000	0.998	0.001
C67.7 Urachus	0.001	0.998	0.000
C67.6 Ureteric orifice	0.002	0.998	0.000
E88.2 Lipomatosis, not elsewhere classified	0.001	0.998	0.000
Q63.2 Ectopic kidney	0.000	0.998	0.001
J40 Bronchitis, not specified as acute or chronic	0.002	0.998	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.002	0.998	0.000
O62.2 Other uterine inertia	0.002	0.998	0.000
S52.6 Fracture of lower end of both ulna and radius	0.002	0.998	0.000
C32.1 Supraglottis	0.000	0.998	0.001
C67.0 Trigone of bladder	0.001	0.998	0.000
L81.9 Disorder of pigmentation, unspecified	0.000	0.998	0.002
M75.8 Other shoulder lesions	0.000	0.998	0.001
N20 Calculus of kidney and ureter	0.002	0.998	0.000
O62.1 Secondary uterine inertia	0.001	0.998	0.000
Q63.8 Other specified congenital malformations of kidney	0.000	0.998	0.001
E21.0 Primary hyperparathyroidism	0.000	0.998	0.001
Q63.3 Hyperplastic and giant kidney	0.000	0.998	0.001
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.000	0.998	0.002
Z90.1 Acquired absence of breast(s)	0.002	0.998	0.000
M75.81 Other shoulder lesions, right shoulder	0.000	0.999	0.001
C67.3 Anterior wall of bladder	0.001	0.999	0.000
H20.0 Acute and subacute iridocyclitis	0.000	0.999	0.001
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.001	0.999	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.001	0.999	0.000
N20.9 Urinary calculus, unspecified	0.001	0.999	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.999	0.001
S64.4 Injury of digital nerve of other finger	0.000	0.999	0.001
N23 Unspecified renal colic	0.001	0.999	0.000
H16.4 Corneal neovascularisation	0.000	0.999	0.001
H16.3 Interstitial and deep keratitis	0.000	0.999	0.001
L85.8 Other specified epidermal thickening	0.001	0.999	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.001	0.999	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.001	0.999	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
W22.9 Unspecified place	0.001	0.999	0.000
M71.29 Synovial cyst of popliteal space [Baker]-Site unspec	0.000	0.999	0.001
M71.28 Synovial cyst of popliteal space [Baker]-Other	0.000	0.999	0.001
M71.27 Synovial cyst of popliteal space [Baker]-Ankle/Foot	0.000	0.999	0.001
M71.25 Synovial cyst of popliteal space [Baker]-Pelvic/Thigh	0.000	0.999	0.001
M71.24 Synovial cyst of popliteal space [Baker]-Hand	0.000	0.999	0.001
M71.23 Synovial cyst of popliteal space [Baker]-Forearm	0.000	0.999	0.001
M71.22 Synovial cyst of popliteal space [Baker]-Upper arm	0.000	0.999	0.001
M71.21 Synovial cyst of popliteal space [Baker]-Shldr region	0.000	0.999	0.001
M71.20 Synovial cyst of popliteal space [Baker]-Mult sites	0.000	0.999	0.001
H93.1 Tinnitus	0.001	0.999	0.000
N20.2 Calculus of kidney with calculus of ureter	0.001	0.999	0.000
F22 Persistent delusional disorders	0.000	0.999	0.001
M71.12 Other infective bursitis (Upper arm)	0.000	0.999	0.001
J84.9 Interstitial pulmonary disease, unspecified	0.001	0.999	0.000
O62.8 Other abnormalities of forces of labour	0.001	0.999	0.000
H16 Keratitis	0.000	0.999	0.001
C50.5 Lower-outer quadrant of breast	0.001	0.999	0.000
E89.3 Postprocedural hypopituitarism	0.001	0.999	0.000
J03.9 Acute tonsillitis, unspecified	0.000	0.999	0.001
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.001	0.999	0.000
L03.0 Cellulitis of finger and toe	0.000	0.999	0.001
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.999	0.001
N99.5 Malfunction of external stoma of urinary tract	0.001	0.999	0.000
O62.9 Abnormality of forces of labour, unspecified	0.001	0.999	0.000
H53.4 Visual field defects	0.000	0.999	0.001
H81.2 Vestibular neuronitis	0.001	0.999	0.000
I45.1 Other and unspecified right bundle-branch block	0.001	0.999	0.000
M71.1 Other infective bursitis	0.000	0.999	0.001
S09.8 Other specified injuries of head	0.000	0.999	0.001
M71 Other bursopathies	0.000	0.999	0.001
C67.8 Overlapping lesion of bladder	0.001	0.999	0.000
E89.2 Postprocedural hypoparathyroidism	0.001	0.999	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.001	0.999	0.000
J84 Other interstitial pulmonary diseases	0.001	0.999	0.000
S09 Other and unspecified injuries of head	0.000	0.999	0.001
C67.2 Lateral wall of bladder	0.001	0.999	0.000
M71.9 Bursopathy, unspecified	0.000	0.999	0.001
O62.0 Primary inadequate contractions	0.001	0.999	0.000
F31 Bipolar affective disorder	0.001	0.999	0.000
H81 Disorders of vestibular function	0.001	0.999	0.000
Z33 Pregnant state, incidental	0.000	0.999	0.001
F22.8 Other persistent delusional disorders	0.000	0.999	0.001
H16.8 Other keratitis	0.000	0.999	0.001
J15.0 Pneumonia due to Klebsiella pneumoniae	0.001	0.999	0.000
M71.8 Other specified bursopathies	0.000	0.999	0.001
T83.3 Mechanical complication of intra-uterine contraceptive device	0.001	0.999	0.000
F22.9 Persistent delusional disorder, unspecified	0.000	0.999	0.001
J15.2 Pneumonia due to staphylococcus	0.001	0.999	0.000
J98.9 Respiratory disorder, unspecified	0.000	0.999	0.001
M71.0 Abscess of bursa	0.000	0.999	0.001
N83.0 Follicular cyst of ovary	0.001	0.999	0.000
S09.7 Multiple injuries of head	0.000	0.999	0.001
S09.2 Traumatic rupture of ear drum	0.000	0.999	0.001
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.000	0.999	0.001
H20 Iridocyclitis	0.000	0.999	0.001
M71.96 Bursopathy, unspecified (Lower leg)	0.000	0.999	0.001
A08.4 Viral intestinal infection, unspecified	0.000	0.999	0.001
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.001	0.999	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.001	0.999	0.000
H16.2 Keratoconjunctivitis	0.000	0.999	0.001
H16.1 Other superficial keratitis without conjunctivitis	0.000	0.999	0.001
N81.1 Cystocele	0.000	0.999	0.001
S09.0 Injury of blood vessels of head, not elsewhere classified	0.000	0.999	0.001
G37 Other demyelinating diseases of central nervous system	0.001	0.999	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.000	0.999	0.001
N20-N23 Urolithiasis	0.001	0.999	0.000
M71.19 Other infective bursitis (Site unspecified)	0.000	0.999	0.001
M71.18 Other infective bursitis (Other)	0.000	0.999	0.001
M71.17 Other infective bursitis (Ankle and foot)	0.000	0.999	0.001
M71.15 Other infective bursitis (Pelvic region and thigh)	0.000	0.999	0.001
M71.14 Other infective bursitis (Hand)	0.000	0.999	0.001
M71.13 Other infective bursitis (Forearm)	0.000	0.999	0.001
M71.11 Other infective bursitis (Shoulder region)	0.000	0.999	0.001
M71.10 Other infective bursitis (Multiple sites)	0.000	0.999	0.001
M71.97 Bursopathy, unspecified (Ankle and foot)	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations